THCV235

THCV235 isn’t a standard, widely recognized term. If you meant THCV (tetrahydrocannabivarin), here’s a quick intro:
- What it is: a naturally occurring cannabinoid, a structural variant of THC with a propyl side chain.
- Occurrence: a minor constituent in cannabis, usually in small amounts.
- Pharmacology: interacts with CB1/CB2 receptors; often described as a CB1 antagonist/inverse agonist at low doses, with different effects than THC and typically shorter-acting.
- Effects: can be more energizing and less sedating than THC; some reports suggest appetite-suppressing properties.
- Therapeutic potential: explored for metabolic health (obesity, diabetes), anticonvulsant and anti-inflammatory effects; research is early-stage.
- Safety/considerations: generally well tolerated but can cause tachycardia, dizziness or anxiety at higher doses; effects can vary with formulation and other cannabinoids.
- Legal status: varies by country/state; check local regulations.
If you indeed meant a specific product or code “THCV235,” please provide context so I can tailor the answer.

THCV235 is an 8‑pin device, commonly in a VSSOP‑8 package (about 3×3 mm). Some variants may also be available in SOIC‑8; check the exact datasheet for the specific package option.

THCV235 is not uniquely defined across vendors. There are multiple parts with the THCV prefix, each with different pin counts and functions. Please provide the manufacturer or a link to the datasheet. With that, I can give you the exact pin count and function (e.g., which pins are Vcc/GND, I/O, control, etc.).

- Manufacturer: Texas Instruments (TI)
- What kind of company: A global semiconductor company that designs and manufactures analog and embedded processing integrated circuits.

Assuming THCV235 refers to tetrahydrocannabivarin (THCV), common application areas include: metabolic/weight-management and potential insulin sensitivity benefits; neuroprotection and possible anticonvulsant/anti-anxiety effects; anti-inflammatory and analgesic properties; use in cannabis-based formulations to modulate psychoactivity and synergy with CBD/THC; and pharmacology research on CB1 receptor activity and endocannabinoid signaling.